| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,716 |
2,680 |
$124K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,913 |
1,838 |
$68K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,132 |
422 |
$25K |
| 99222 |
Initial hospital care, per day, moderate complexity |
608 |
603 |
$24K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,920 |
609 |
$23K |
| 93458 |
|
43 |
43 |
$5K |
| 93000 |
|
783 |
778 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
39 |
39 |
$4K |
| 99223 |
Prolong inpt eval add15 m |
56 |
51 |
$3K |
| 99152 |
|
107 |
104 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
78 |
70 |
$831.40 |
| 93015 |
|
51 |
51 |
$714.81 |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$570.00 |
| 99233 |
Prolong inpt eval add15 m |
26 |
12 |
$378.44 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12 |
12 |
$100.32 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
51 |
51 |
$96.39 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12 |
12 |
$41.52 |
| 4086F |
|
848 |
823 |
$0.00 |
| 1036F |
|
12 |
12 |
$0.00 |
| 1123F |
|
253 |
234 |
$0.00 |
| 4008F |
|
312 |
307 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
677 |
660 |
$0.00 |
| G9189 |
Beta-blocker therapy prescribed or currently being taken |
65 |
64 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
814 |
791 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
523 |
512 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
342 |
330 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
27 |
27 |
$0.00 |
| 1124F |
|
74 |
72 |
$0.00 |
| A9505 |
Thallium tl-201 thallous chloride, diagnostic, per millicurie |
38 |
38 |
$0.00 |
| 1090F |
|
12 |
12 |
$0.00 |